Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Marksans Pharma Ltd.
Swot
Marksans Pharma Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Marksans Pharma Ltd. has 8 Strengths, 7 Weaknesses, 2 Opportunities and 0 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(8)
Weakness
(7)
Opportunity
(2)
Threats
(0)
Others
(4)
Benjamin Graham Value Screen
Mid-range Performer (DVM)
Growth in Net Profit with increasing Profit Margin (QoQ)
Companies with Low Debt
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
Stocks Outperforming their Industry Price Change in the Quarter
Companies with growing costs YoY for long term projects
PEG greater than Industry PEG
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years
Increasing Trend in Non-Core Income
RSI indicating price weakness
Top Losers
MFs increased their shareholding last quarter
Mutual Funds Increased Shareholding over the Past Two Months
Stocks with improving cash flow, with good durability
Big Changes up or down in FII holding
Average Financial Performers - Stocks with Medium Trendlyne Durability Score versus Benchmarks
Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks
